Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial.
Goldner G, Bombosch V, Geinitz H, Becker G, Wachter S, Glocker S, Zimmermann F, Wachter-Gerstner N, Schrott A, Bamberg M, Molls M, Feldmann H, Pötter R. Goldner G, et al. Among authors: bombosch v. Strahlenther Onkol. 2009 Feb;185(2):94-100. doi: 10.1007/s00066-009-1970-3. Epub 2009 Feb 25. Strahlenther Onkol. 2009. PMID: 19240995 Clinical Trial.
Late gastrointestinal and urogenital side-effects after radiotherapy--incidence and prevalence. Subgroup-analysis within the prospective Austrian-German phase II multicenter trial for localized prostate cancer.
Schmid MP, Pötter R, Bombosch V, Sljivic S, Kirisits C, Dörr W, Goldner G. Schmid MP, et al. Among authors: bombosch v. Radiother Oncol. 2012 Jul;104(1):114-8. doi: 10.1016/j.radonc.2012.05.007. Epub 2012 Jun 23. Radiother Oncol. 2012. PMID: 22727264 Clinical Trial.